Profil
Jay Tibor Novak worked as an Associate Director of Finance at Ionis Pharmaceuticals, Ngen Inc., and Elan Pharmaceuticals.
He also served as the Chief Financial Officer and Secretary at International Stem Cell Corp.
from 2014 to 2015.
Novak holds an undergraduate degree from The California State University and an MBA from the University of California, Irvine.
Anciens postes connus de Jay Tibor Novak
| Sociétés | Poste | Fin |
|---|---|---|
| INTERNATIONAL STEM CELL CORPORATION | Directeur Financier/CFO | 08/05/2015 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
| NGEN INC | Corporate Officer/Principal | - |
Formation de Jay Tibor Novak
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Ngen, Inc.
Ngen, Inc. Medical SpecialtiesHealth Technology Produces and distributes diagnostic products | Health Technology |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Stem Cell Corp.
International Stem Cell Corp. Medical SpecialtiesHealth Technology Operates as a biotechnology company, which focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities | Health Technology |
















